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Introduction: Patients with Brugada electrocardiographic (ECG) patterns have differing
levels of arrhythmic risk. We hypothesized that temporal variations in certain ECG
markers may provide additional value for risk stratification. The present study evaluated
the relationship between temporal variability of ECG markers and arrhythmic outcomes
in patients with a Brugada pattern ECG. Comparisons were made between low-risk
asymptomatic subjects versus high-risk symptomatic patients with a history of syncope,
ventricular tachycardia (VT) or ventricular fibrillation (VF).
Methods: A total of 81 patients presenting with Brugada patterns were recruited. Serial
ECGs and electronic health records from January 2004 to April 2019 were analyzed.
Temporal variability of QRS interval, J point-Tpeak interval (JTp), Tpeak-Tend interval (Tp-
e), and ST elevation (STe) in precordial leads V1-3, in addition to RR-interval from lead II,
was assessed using standard deviation and difference between maximum and minimum
values over the serial ECGs.
Results: Patients presenting with type 1 Brugada ECG pattern initially had significantly
higher variability in JTp from lead V2 (SD: 33.5 ± 13.8 vs. 25.2 ± 11.5 ms, P = 0.009;
max-min: 98.6 ± 46.2 vs. 78.3 ± 47.6 ms, P = 0.047) and ST elevation in lead V1
(0.117 ± 0.122 vs. 0.053 ± 0.030 mV; P = 0.004). Significantly higher variability in Tp-
e interval measured from lead V3 was observed in the VT/VF group compared to the
syncope and asymptomatic groups (SD: 20.5 ± 8.5 vs. 16.6 ± 7.3 and 14.7 ± 9.8 ms;
P = 0.044; max-min: 70.2 ± 28.9 vs. 56.3 ± 29.0 and 43.5 ± 28.5 ms; P = 0.011).
Conclusion: Temporal variability in ECG indices may provide additional value for risk
stratification in patients with Brugada pattern.
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INTRODUCTION
Brugada syndrome (BrS) is an ion channelopathy which
results in characteristic electrocardiographic (ECG) changes
and predisposes patients with increased risk of ventricular
tachycardia (VT), ventricular fibrillation (VF), and sudden
cardiac death (SCD). The stratification of SCD risk is influenced
by many factors, primarily the ECG pattern and symptoms
presented (Gourraud et al., 2017). Syncope, VT and VF are
deemed as strong predictors of SCD, while asymptomatic patients
are considered to be of relatively low risk (Sieira et al., 2016). ECG
markers are being explored for early identification of high-risk
patients before they become symptomatic (Asvestas et al., 2018).
The spatial dispersion of different ECG indices for risk
stratification has been well-explored. However, little analysis has
been performed on their temporal variability. A recent study
has reported significant temporal variability in indices measured
from serial ECGs, with greater variability in patients with type
1 pattern (Castro Hevia et al., 2019). In the past, temporal
variability in ECG indices has been simply attributed to the
recognized dynamicity in Brugada ECG pattern (BrP) (Bayes de
Luna et al., 2012). The recent demonstration of the difference in
temporal variability between patient subgroups (Gray et al., 2017)
inspired our interest to examine the potential use of temporal
variability concerning risk stratification. Hence, the present study
aims to examine the difference in temporal variability of ECG
markers for risk stratification between low-risk asymptomatic
patients, and high-risk symptomatic patients with a history of
syncope, VT, or VF.
METHODS
Patient Selection and
Electrocardiographic Measurement
This study received Ethics Approval from The Joint Chinese
University of Hong Kong – New Territories East Cluster
Clinical Research Ethics Committee (CREC Ref. No.: 2019.338).
Institutional board approval was obtained and waived the need
for patient consent in this retrospective study. The present single-
center cohort consists of patients who visited the Prince of Wales
Hospital, Hong Kong, China from the 1st of January, 2004 to the
1st of April, 2019 with electrocardiogram showing type 1 (cove-
shaped) or type 2 (saddle-shaped) Brugada patterns. Patients
with zero or one electronically documented ECG were excluded.
Discrete ECGs throughout the follow-up duration were analyzed.
The following ECG indices for leads V1, V2, and V3 from 12-lead
ECG were measured using Philips ECGVue (standard edition):
(1) QRS interval; (2) J point-Tpeak interval (J-Tp, interval from
J point to the peak of T wave); (3) Tpeak-Tend interval (Tp-e,
interval from the peak to the end of T wave returning to baseline);
and (4) ST elevation (STe). RR interval was measured from lead
II. ECGs were excluded if (1) artefacts were present in leads V1-
3; (2) QRS complex and T waves were unidentifiable; and (3) the
rhythm was paced.
The patient history was reviewed to identify the presence
of syncope, VT and VF. The cohort was divided into three
groups based on symptoms documented during follow-up:
(1) asymptomatic, (2) syncope, and (3) VT/VF. Patients who
presented with both syncope and VT/VF were included in
both groups. Patients who presented with type 1 Brugada
ECG, and those who did not, were also compared. The
average and temporal dispersion of individual ECG indices were
calculated. Temporal dispersion was calculated by two methods:
(1) maximum – minimum (max-min) value of the index; and (2)
standard deviation (SD) of the index over the series of ECG taken.
Statistical Analysis
Statistical analysis was performed using Stata MP 13. Statistical
significance is defined as P-value <0.05. Intergroup differences
were compared by Kruskal-Wallis’ two-way ANOVA and Fisher’s
exact test for continuous and discrete variables, respectively.
Pairwise comparison was performed for indices with significant
intergroup differences by repeating the Kruskal-Wallis two-
way ANOVA. Intra- and inter-observer agreement was assessed
by the same investigator 4 weeks apart, and by a second
investigator (Supplementary Material). by one-way mixed-
effects individual, and two-way random-effects average absolute-
agreement intraclass correlation coefficient (ICC), respectively
(0 < ICC < 0.4 = poor; 0.4 < ICC < 0.59 = fair;
0.6 < ICC < 0.74 = good; 0.75 < ICC < 1.00 = excellent)
(Cicchetti, 1994).
RESULTS
After excluding patients with fewer than two ECG records, the
cohort comprised 81 patients (initially type 1 = 35.8%, median
follow-up period = 1281 days, interquartile range of follow-up
period = 2571 days, 1150 ECGs analyzed, female = 8.6%, age of
first BrP = 52.5 ± 1.85, age interquartile range = 24.0 years).
All patients were Han Chinese and 79 of the 81 subjects
were probands. The remaining two patients were identified
from family screening. The age of first BrP and patient sex
of the subgroups did not differ significantly (Supplementary
Table 1). Both intra- and inter-observer agreement achieved fair
to excellent quality (ICC > 0.4; Supplementary Tables 2, 3).
Electrocardiographic indices were compared between patients
with an initial type 1 pattern and those who had non-
type 1 patterns (Table 1). The initial type 1 group displayed
significantly longer lead V3 QRS interval (P = 0.021), shorter
lead V3 JTp (P = 0.011), and greater lead V1 ST elevation
(P = 0.000) compared to the non-type 1 group. They also showed
significantly greater temporal dispersion for both lead V2 JTp (P-
value: SD = 0.009, max-min = 0.047) and lead V1 ST elevation
(P-value: SD = 0.004, max-min = 0.001).
Subsequent analyses were conducted by comparing ECG
indices between asymptomatic patients (n = 39), patients with
syncope (n= 38), and patients with VT/VF (n= 13) group. Within
the syncope and VT/VF subgroups, five and two patients in the
respective groups were initially asymptomatic, and developed
syncope or VT/VF over the course of follow-up. A significant
increase in variability was found in Tp-e measured form lead
V3 under both standard deviation (P = 0.044) and maximum –
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TABLE 1 | ECG biomarkers for initial type 1 vs. non-type 1 patterns.
Overall (n = 81) Non-type 1 (n = 52) Type 1 (n = 29) P-value
Average
RR 863 ± 112 880 ± 118 833 ± 95.2 0.096
QRSV1 104 ± 13.5 102 ± 13.4 107 ± 13.3 0.085
QRSV2 110 ± 15.0 108 ± 15.8 113 ± 13.1 0.127
QRSV3 111 ± 14.8 108 ± 15.6 115 ± 12.4 0.021
JTpV1 202 ± 26.7 203 ± 29.4 201 ± 21.2 0.436
JTpV2 181 ± 25.9 181 ± 26.2 180 ± 25.9 0.825
JTpV3 175 ± 23.9 180 ± 24.7 166 ± 19.9 0.011
TpeV1 83.7 ± 15.4 82.6 ± 14.6 85.6 ± 16.7 0.640
TpeV2 101 ± 14.5 102 ± 14.5 101 ± 14.8 0.598
TpeV3 105 ± 14.6 106 ± 13.3 103 ± 16.8 0.220
STeV1 0.146 ± 0.143 0.101 ± 0.081 0.227 ± 0.189 0.000
STeV2 0.297 ± 0.159 0.277 ± 0.139 0.334 ± 0.187 0.285
STeV3 0.138 ± 0.080 0.133 ± 0.071 0.149 ± 0.096 0.910
Dispersion: SD
RR 86.6 ± 40.4 84.8 ± 43.3 89.9 ± 35.3 0.509
QRSV1 12.1 ± 8.03 11.0 ± 6.12 14.1 ± 10.5 0.241
QRSV2 14.6 ± 9.73 14.2 ± 10.1 15.2 ± 9.24 0.503
QRSV3 10.9 ± 4.73 10.4 ± 4.80 11.9 ± 4.55 0.138
JTpV1 23.7 ± 13.3 25.3 ± 14.1 20.9 ± 11.4 0.215
JTpV2 28.2 ± 12.9 25.2 ± 11.5 33.5 ± 13.8 0.009
JTpV3 21.4 ± 13.1 20.7 ± 10.9 22.6 ± 16.5 0.922
TpeV1 17.3 ± 7.59 18.1 ± 8.25 15.9 ± 6.11 0.428
TpeV2 20.6 ± 10.2 19.2 ± 9.31 23.2 ± 11.4 0.126
TpeV3 16.0 ± 8.83 15.2 ± 6.80 17.4 ± 11.6 0.828
STeV1 0.076 ± 0.082 0.053 ± 0.030 0.117 ± 0.122 0.004
STeV2 0.127 ± 0.087 0.123 ± 0.089 0.135 ± 0.084 0.419
STeV3 0.070 ± 0.050 0.065 ± 0.052 0.079 ± 0.046 0.159
Dispersion: Max-Min
RR 277 ± 155 274 ± 163 280 ± 144 0.863
QRSV1 39.7 ± 28.5 35.7 ± 25.6 46.8 ± 32.2 0.153
QRSV2 46.6 ± 31.5 43.0 ± 28.5 53.0 ± 35.8 0.268
QRSV3 34.8 ± 20.4 33.1 ± 20.5 37.8 ± 20.3 0.339
JTpV1 75.5 ± 45.3 78.8 ± 46.7 69.4 ± 42.8 0.342
JTpV2 85.6 ± 47.9 78.3 ± 47.6 98.6 ± 46.2 0.047
JTpV3 66.1 ± 44.6 63.6 ± 38.9 70.5 ± 53.8 0.957
TpeV1 53.8 ± 27.1 55.6 ± 29.2 50.6 ± 23.0 0.509
TpeV2 63.5 ± 35.5 58.2 ± 33.1 73.0 ± 38.2 0.081
TpeV3 50.8 ± 29.2 48.4 ± 27.3 55.0 ± 32.4 0.454
STeV1 0.210 ± 0.225 0.146 ± 0.123 0.324 ± 0.310 0.001
STeV2 0.367 ± 0.267 0.338 ± 0.251 0.417 ± 0.292 0.204
STeV3 0.191 ± 0.145 0.175 ± 0.138 0.221 ± 0.154 0.239
Units in milliseconds or millivolts. Variables with P < 0.05 are shown in bold text.
minimum (P = 0.011) calculations, as shown in Table 2. Under
further pairwise comparison, VT/VF group had significantly
greater temporal dispersion in comparison to the asymptomatic
group with both standard deviation (P = 0.021) and maximum –
minimum (P = 0.007) methods, and to the syncope group under
maximum- minimum (P = 0.046) calculation. Furthermore, the
average extent of STe in lead V3 is significantly higher in VT/VF
TABLE 2 | ECG biomarkers categorized based on symptoms.
Asymptomatic (n = 39) Syncope (n = 38) VT/VF (n = 13) P-value
Average
RR 870 ± 104 857 ± 126 835 ± 103 0.564
QRSV1 105 ± 13.8 103 ± 13.8 106 ± 17.5 0.712
QRSV2 109 ± 15.4 111 ± 15.5 115 ± 17.1 0.631
QRSV3 111 ± 15.6 111 ± 14.9 114 ± 16.1 0.873
JTpV1 200 ± 30.2 205 ± 23.3 203 ± 27.2 0.841
JTpV2 191 ± 27.6 182 ± 25.2 177 ± 31.8 0.706
JTpV3 173 ± 23.0 179 ± 24.8 168 ± 31.9 0.185
TpeV1 86.7 ± 17.5 80.4 ± 12.7 86.7 ± 15.1 0.203
TpeV2 105 ± 16.6 97.8 ± 12.1 100 ± 9.73 0.121
TpeV3 108 ± 15.2 102 ± 14.2 108 ± 10.3 0.193
STeV1 0.135 ± 0.132 0.164 ± 0.159 0.168 ± 0.159 0.922
STeV2 0.326 ± 0.168 0.269 ± 0.145 0.254 ± 0.153 0.111
STeV3 0.160 ± 0.090 0.120 ± 0.066 0.097 ± 0.051 0.017
Dispersion: SD
RR 85.0 ± 46.0 88.0 ± 36.1 74.4 ± 29.8 0.417
QRSV1 13.2 ± 9.9 11.2 ± 5.4 13.9 ± 6.37 0.487
QRSV2 13.5 ± 9.9 16.3 ± 9.8 12.4 ± 6.6 0.259
QRSV3 10.9 ± 5.0 11.4 ± 4.6 9.58 ± 3.6 0.397
JTpV1 23.7 ± 13.5 24.7 ± 13.6 21.4 ± 7.6 0.876
JTpV2 30.5 ± 15.5 25.9 ± 9.6 26.6 ± 9.7 0.598
JTpV3 23.3 ± 16.3 20.1 ± 9.4 19.4 ± 10.1 0.731
TpeV1 17.7 ± 8.90 17.2 ± 6.5 16.5 ± 5.8 0.929
TpeV2 20.9 ± 12.0 20.3 ± 8.5 21.4 ± 6.6 0.725
TpeV3 14.7 ± 9.8 16.6 ± 7.3 20.5 ± 8.5 0.044
STeV1 0.073 ± 0.065 0.082 ± 0.100 0.065 ± 0.041 0.984
STeV2 0.134 ± 0.090 0.122 ± 0.086 0.118 ± 0.074 0.778
STeV3 0.081 ± 0.061 0.061 ± 0.037 0.064 ± 0.039 0.201
Dispersion: Max-Min
RR 251 ± 163 300 ± 153 288 ± 118 0.125
QRSV1 40.6 ± 32.3 40.0 ± 25.1 49.1 ± 26.2 0.467
QRSV2 39.5 ± 29.9 55.6 ± 32.5 47.9 ± 27.4 0.077
QRSV3 31.8 ± 20.2 38.9 ± 21.0 37.1 ± 20.8 0.270
JTpV1 69.8 ± 43.1 83.7 ± 48.4 77.5 ± 34.1 0.460
JTpV2 83.5 ± 51.1 87.7 ± 46.5 95.8 ± 47.2 0.638
JTpV3 66.0 ± 52.8 67.3 ± 37.2 71.8 ± 45.6 0.565
TpeV1 50.6 ± 27.8 57.7 ± 27.6 58.4 ± 23.0 0.535
TpeV2 57.2 ± 33.4 69.6 ± 37.6 80.9 ± 37.9 0.080
TpeV3 43.5 ± 28.5 56.3 ± 29.0 70.2 ± 28.9 0.011
STeV1 0.182 ± 0.150 0.250 ± 0.287 0.238 ± 0.218 0.835
STeV2 0.349 ± 0.236 0.289 ± 0.306 0.400 ± 0.277 0.894
STeV3 0.215 ± 0.160 0.174 ± 0.133 0.208 ± 0.171 0.405
Units in milliseconds or millivolts. Variables with P < 0.05 are shown in bold text.
group in comparison to both the syncope (P = 0.039) and the
asymptomatic group (P = 0.010) under pairwise comparison.
DISCUSSION
The present study demonstrates that increased temporal
variability in Tp-e is found in patients with Brugada pattern of
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higher SCD risk. Tp-e has been used to quantify the transmural
dispersion of ventricular repolarization and used in BrS risk-
stratification (Xia et al., 2005; Tse et al., 2018a). Increased
transmural dispersion prolongs ventricular repolarization, which
can lead to re-entry in phase 2 and subsequently ventricular
tachyarrhythmia (Yan and Antzelevitch, 1999). Although the
dynamicity of the Brugada pattern is well known, the significance
of temporal variability in the risk stratification of BrS patients
has not been fully explored (Viskin et al., 2018). The significant
temporal variability in Tp-e amongst the high-risk arrhythmic
group suggests the presence of a temporal variation in the
transmural repolarization dispersion, and increased ventricular
repolarization instability may explain the marked increase
SCD risk in the symptomatic group. The fluctuations in the
extent of transmural dispersion are further supported by the
insignificant difference in Tp-e, and the dynamic manifestation
of Brugada ECG pattern (Antzelevitch et al., 2005). Differing
with the study by Castro Hevia et al. (2019), significant
temporal variability was not noted in QRS duration in the
present study, which might be attributed to the difference in
calculation methodology. The significant intergroup differences
in the average value of ECG indices is due to the diverse
electrocardiographic pattern.
Although the diagnosis of Brugada syndrome focuses on the
characteristic ECG pattern in leads V1 and V2, the present study
demonstrates that lead V3 can also be useful in risk stratification.
Information from lead V3 is often considered to be redundant
in the clinical diagnosis of Brugada syndrome since it is less
sensitive than leads V1-2 for Brugada ECG changes (Govindan
et al., 2010). However, the present findings suggest that lead V3
might be able to provide insights into risk stratification through
its sensitivity for ECG variability, and for which further research
is needed to explore its clinical value in variability detection. It
has been reported that Tp-e is longest in V3 when measured in
children, possibly due to a higher number of M cells distributed
in the interventricular septum (Bieganowska et al., 2013). The
difference in temporal variability across the leads highlights the
heterogeneity in ventricular repolarization of Brugada patients.
Further research on the spatiotemporal dispersion of ECG indices
is needed to elucidate the dynamicity in Brugada pattern.
The insignificant difference between the asymptomatic and
syncope groups could be explained by the exact etiology of
syncope. It has been reported that whilst patients presenting with
unexplained syncope and a positive electrophysiological study are
at high risk for arrhythmia, those with neurally mediated syncope
share a similar prognosis to asymptomatic patients (Giustetto
et al., 2017). Furthermore, there is growing evidence for similar
genetic mutations to be present in both epilepsy and BrS. Syncope
of such potential non-cardiogenic origins is unlikely to be affected
by temporal variability of cardiac conduction and repolarisation,
which might explain the insignificant results (Parisi et al., 2013;
Tiron et al., 2015).
To reduce bias in ECG analysis, automatic measurements by
the ECG machine can be applied. However, a comparison should
be made against manual measurements to confirm accuracy in
the detection of different ECG features, for example, the J point
in Brugada ECGs. Future studies should further evaluate the
use of automatic measurements in all ECG parameters analyzed
in the present study and assess the clinical applications of the
ECG parameters, particularly Tp-e. Whilst clinical studies have
demonstrated that prolonged Tp-e reflects the presence of a
resolved, temporary, arrhythmogenic substrate in patients with
acute myocardial infarction, and predicts mortality for these
patients, further research is required to explore its applicability
in outcome prediction for spontaneous arrhythmia due to a
channelopathy (Haarmark et al., 2009; Elitok et al., 2015).
Strengths and Limitations
There are several notable strengths of the present study. Firstly,
a comprehensive analysis of different ECG features has been
performed, with 3–50 ECGs measured per patient, and a total of
more than 1000 ECGs analyzed. This extended previous studies
using only single ECG measurements at baseline (Tse et al.,
2018b; Lee et al., 2020). Moreover, there is good inter and intra-
observer variability, as reflected by the intra-class coefficient.
Several limitations should also be noted for the present study.
First, the cohort is small and from a single center, hence findings
should be externally validated and tested in a separate larger
cohort in the future. Gender differences were not explored in
the present study due to the limited number of female patients
(n = 7). Since the majority of the patients were distributed in the
middle ages (median age of first Brugada BrP onset = 53.0 years,
interquartile range = 20.0 years), in addition to the relatively small
cohort, the age differences were not examined. Unfortunately,
only two patients undergone genetic testing in the present cohort,
hence their genetic status cannot be commented upon. Moreover,
the retrospective nature of the present study is susceptible to
the bias inherent to such analyses. Besides, the sensitivity of
the caliper used in measurement is limited by its one-decimal-
place display, which results in a larger error in measuring small
values, such as STe. The intervals between serial ECGs taken is
variable between patients, and within a single patient, with more
ECGs taken when the patients are less stable. Therefore, the ECG
indices measured may tend to reflect a state of instability Errors
may also be introduced in view of different operators undertaking
the ECGs on different days. Furthermore, the relatively short
follow-up duration limits the predictive value of the ECG
parameters found toward patient life expectancy.
CONCLUSION
The present study demonstrates the presence of increased
temporal variability in Tp-e amongst high-risk BrS patients,
which illustrates a potential role for the analysis of serial changes
in the surface ECG in the prognostic workup of BrS. Further
research into the spatiotemporal dispersion of Brugada ECG
patterns is need to gain insights into the dynamicity of Brugada
electrophysiological changes.
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